Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06449352
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-06-03
Brief Title:
Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost
Sponsor:
Westlake Eye Specialists
Organization:
Westlake Eye Specialists
Study Overview
Official Title:
Effect of the Addition of Netarsudil 002 vs Brimonidine 01 in Normal Tension Glaucoma Patients Currently on Latanoprost 0005
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A randomized multicenter investigator-masked prospective study of NTG patients currently on latanoprost 0005 monotherapy to study the effect of IOP change with the introduction of netarsudil 002 vs brimonidine 01 Subjects will be assessed at a screening visit and 1 follow-up visit Clinical evaluations will include visual acuity and IOP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None